Metraipolis › archive › dc_715919bf359a

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials — Europe PMC PMID:41787737

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41787737
DOI: 10.1002/edm2.70187
License (as archived): solo-consultazione
Archived: 2026-11-05T11:57:16.644Z
SHA-256 of the archived text: a0653927f3ab6058c064da0aaf530c7464d8fd4b185b1320bb8738d9085a2e72
Stable URL of this page: https://metraipolis.com/documento/dc_715919bf359a

How to cite

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials — Europe PMC PMID:41787737 — Europe PMC (en), https://europepmc.org/article/MED/41787737 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_715919bf359a (Metraipolis archive dc_715919bf359a, sha256 a0653927f3ab6058c064da0aaf530c7464d8fd4b185b1320bb8738d9085a2e72)

BibTeX

@misc{dc715919bf359a,
  title = {Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials — Europe PMC PMID:41787737},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41787737},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_715919bf359a; sha256 a0653927f3ab6058c064da0aaf530c7464d8fd4b185b1320bb8738d9085a2e72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41787737. Agents can read the archived copy with the MCP tool read_document.